Case Studies

When faced with evolving analysis plans, minimal client infrastructure, and shifting output volumes, Phastar delivere...

Phastar supported a sponsor in delivering a high-quality Integrated Summary of Safety (ISS) for a rare disease progra...

Integrating efficacy and safety data across multiple studies is never simple—especially when patient-reported outcome...

After acquiring a biotech, a global pharma company faced major issues with two ongoing pharmacokinetic studies—both f...

When a top 20 global pharmaceutical company issued a competitive RFP seeking support in statistical programming and d...

A new predictive tool built from NHS data helps identify patients most at risk of kidney disease and retinopathy. It ...

If your clinical data review process feels slow, fragmented, or error-prone, this case study shows how Phastar and Be...

How Phastar Rescued 12 Studies and Became a Long-Term Strategic Partner. Discover how Phastar stepped in to rescue mu...

Delays in patient recruitment can derail even the most well-designed clinical trials. Discover how Phastar’s Recruitm...

A customer managing a high-profile clinical trial faced significant challenges due to their reliance on Excel for tri...

This project was a collaboration between Kopenhagen Konsulting and Phastar Denmark. KK Management Konsulting lead the...

Phastar was engaged to rescue another CROs reporting of a large phase III study in mild asthmatics to evaluate the ef...

Hepatitis B virus (HBV) infection is among the most common persistent viral infections in humans. Chronic infection o...

A new formulation under investigation was planned to be submitted for use in both the US and Europe. As the reference...

Phastar was awarded as a preferred supplier to a top 20 pharmaceutical sponsor, supporting five new studies per year....

Phastar was contracted to assist a pharmaceutical company with the conversion of 16 legacy studies to SDTM (2 SDTM “L...

Phastar was contracted to assist a global pharmaceutical company with their integrated summary of safety and efficacy...

Phastar provided a team of statisticians and programmers to deliver the analysis and reporting of a program of four t...

Following the completion of an early phase clinical trial, the sponsor was planning a larger phase IIb study with the...

Phastar began a relationship with a top ten pharmaceutical company carrying out statistical consultancy and were subs...

Case study PHASTAR was engaged to report a phase I/II oncology study in advanced NSCLC with an initial phase I escala...

Phastar has a number of sponsor relationships where we provide teams of statisticians and statistical programmers to ...